Loading…

Loading grant details…

Completed HORIZON European Commission

BioProtect Balloon Implant System – Enabling Safe Prostate Radiation Treatment even at extreme dosage

€5.5M EUR

Funder European Commission
Recipient Organization Bioprotect Ltd
Country Israel
Start Date Oct 01, 2023
End Date Sep 30, 2025
Duration 730 days
Number of Grantees 1
Roles Coordinator
Data Source European Commission
Grant ID 190160766
Grant Description

Prostate is the 2nd leading cancer in men in the world, with more than 1.4 million men diagnosed every year globally. ~50% of men will be treated with radiation treatment.

Radiation is a highly effective treatment; however, it has significant complications, mainly injuring the rectal tissue, approximate to the prostate treatment area.

Up to 35% of the patients will experience rectal toxicity side effects such as bleeding, urinary, bowl and erectile dysfunction, damaging severely patients quality of life. There is a growing need for a solution that protects the rectum from the radiation field.

Our soluton ProSpace is a biodegradable medical grade copolymer (70:30 Poly L-Lactide-co--Caprolactone) balloon spacer deployed in the prostate-rectum interspace.

It creates a 1.8cm, symmetric distance between the prostate & rectum, allowing physicians to radiate prostate tumours & sparing healthy rectal tissue.

All Grantees

Bioprotect Ltd

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant